Brilinta 60 Mg

Medicine Overview

Brilinta 60 mg contains ticagrelor, an effective antiplatelet agent used to prevent blood clots in patients at risk of heart attack or stroke, particularly following acute coronary syndrome. By inhibiting platelet aggregation, Brilinta 60 mg helps maintain smooth blood flow and reduces the risk of serious cardiovascular events. This lower-dose option is suitable for adults requiring ongoing cardiovascular protection under medical supervision. Brilinta 60 mg supports improved heart health, helping to prevent recurrent complications and enhance long-term outcomes. Trusted for its fast action and reliable efficacy, it is a key component in managing cardiovascular risk.